Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Shares Outstanding (Weighted Average) (2020 - 2025)

Cytek Biosciences filings provide 6 years of Shares Outstanding (Weighted Average) readings, the most recent being $127.6 million for Q2 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 2.7% to $127.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was $127.6 million, a 2.7% decrease, with the full-year FY2023 number at $135.3 million, up 0.57% from a year prior.
  • Shares Outstanding (Weighted Average) hit $127.6 million in Q2 2025 for Cytek Biosciences, down from $131.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $135.9 million in Q2 2023 to a low of $31.6 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $132.5 million (2022), compared with a mean of $112.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 324.31% in 2022 and later dropped 3.49% in 2024.
  • Cytek Biosciences' Shares Outstanding (Weighted Average) stood at $76.7 million in 2021, then skyrocketed by 75.28% to $134.5 million in 2022, then increased by 0.57% to $135.3 million in 2023, then decreased by 3.08% to $131.1 million in 2024, then decreased by 2.66% to $127.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $127.6 million (Q2 2025), $131.1 million (Q3 2024), and $131.2 million (Q2 2024) per Business Quant data.